Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.

Individuals carrying melanocortin 1 receptor gene variants have an increased risk for the development of cutaneous melanoma. Melanocortin 1 receptor gene variants are also associated with other risk factors for melanoma such as fair skin and red hair. We evaluated the relationship of melanocortin 1 receptor gene variants, fair skin, red hair and the development of melanoma in 123 patients with cutaneous melanoma and 385 control subjects. To analyze the association between melanocortin 1 receptor gene variants and skin type or hair color we also made use of 453 patients with nonmelanoma skin cancer. We analyzed the coding sequence of the melanocortin 1 receptor gene region by single-stranded conformation polymorphism analysis, followed by DNA sequence analysis. Risk of melanoma dependent on the various melanocortin 1 receptor variant alleles was estimated by exposure odds ratios. The analyses of all different melanocortin 1 receptor gene variants combined, showed that the presence of melanocortin 1 receptor gene variants amounted to a higher melanoma risk, which, in stratified analyses, was independent of skin type and hair color. The odds ratios after adjusting for skin type were 3.6 (95% CI 1.7-7.2) for two variants and 2.7 (95% CI 1.5-5.1) for one variant, respectively. Compound heterozygotes and homozygotes for the Val60Leu, Val92Met, Arg142His, Arg151Cys, Arg160Trp, Arg163Gln, and His260Pro variants had odds ratios of about 4 to develop melanoma, whereas heterozygotes for these variants had half the risk. The presence of the melanocortin 1 receptor gene variant Asp84Glu appeared to impose the highest risk for cutaneous melanoma with odds ratios of 16.1 (95% CI 2.3-139.0) and 8.1 (95% CI 1.2-55.9) in compound heterozygotes and heterozygotes, respectively. The broad confidence intervals, when the different variants were analyzed separately, however, do not allow drawing definite conclusions about the magnitude of these risks. Of the more frequently occurring melanocortin 1 receptor variant alleles the Asp84Glu, Arg142His, Arg151Cys, Arg160Trp, His260Pro, and Asp294His variants were strongly associated with both fair skin and red hair. The Val60Leu, Val92Met, and Arg163Gln variant alleles, however, were only weakly or not associated with fair skin type and/or red hair, which further illustrates the finding that skin type, hair color, and melanoma are independent outcomes of the presence of melanocortin 1 receptor gene variants. We conclude that numerous melanocortin 1 receptor variants predispose to cutaneous melanoma and that possibly the Asp84Glu variant confers the highest risk. This predisposition is largely independent of skin type and hair color.

[1]  R. Westendorp,et al.  Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. , 2001, American journal of human genetics.

[2]  D. Duffy,et al.  Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma. , 2001, The Journal of investigative dermatology.

[3]  I. Jackson,et al.  Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. , 2000, Human molecular genetics.

[4]  J. Haycock,et al.  α-Melanocyte-stimulating Hormone Reduces Impact of Proinflammatory Cytokine and Peroxide-generated Oxidative Stress on Keratinocyte and Melanoma Cell Lines* , 2000, The Journal of Biological Chemistry.

[5]  I. Jackson,et al.  Evidence for variable selective pressures at MC1R. , 2000, American journal of human genetics.

[6]  I. Jackson,et al.  Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair , 2000, The Lancet.

[7]  J. Wikberg,et al.  Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. , 1999, Biochemical and biophysical research communications.

[8]  I. Jackson,et al.  Skin type, melanoma, and melanocortin 1 receptor variants. , 1999, The Journal of investigative dermatology.

[9]  M. González-Barón,et al.  Cutaneous malignant melanoma and sun exposure in Spain. , 1999, Melanoma research.

[10]  W. Thomson,et al.  Susceptibility to melanoma: influence of skin type and polymorphism in the melanocyte stimulating hormone receptor gene. , 1998, The Journal of investigative dermatology.

[11]  I. Jackson,et al.  Melanocortin 1 receptor variants in an Irish population. , 1998, The Journal of investigative dermatology.

[12]  G. Ghanem,et al.  Modulation of ICAM‐1 expression by α‐MSH in human melanoma cells and melanocytes , 1998, Journal of cellular physiology.

[13]  R. Paus,et al.  Cutaneous Immunomodulation and Coordination of Skin Stress Responses by α‐Melanocyte‐Stimulating Hormone a , 1998 .

[14]  P. Frändberg,et al.  Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor. , 1998, Biochemical and biophysical research communications.

[15]  Ghanem,et al.  α‐melanocyte stimulating hormone inhibits tumour necrosis factor‐α stimulated intercellular adhesion molecule‐1 expression in normal cutaneous human melanocytes and in melanoma cell lines , 1998, The British journal of dermatology.

[16]  N. Martin,et al.  Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair. , 1997, Human molecular genetics.

[17]  I. Jackson,et al.  The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. , 1996, Human molecular genetics.

[18]  A. Chakraborty,et al.  Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. , 1996, Biochimica et biophysica acta.

[19]  G. Barsh,et al.  The genetics of pigmentation: from fancy genes to complex traits. , 1996, Trends in genetics : TIG.

[20]  R. Cone,et al.  Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. , 1996, Endocrinology.

[21]  A. Katsambas,et al.  Cutaneous Malignant Melanoma and Sun Exposure: Recent Developments in Epidemiology , 1996 .

[22]  Ian Jackson,et al.  Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans , 1995, Nature Genetics.

[23]  D. Easton,et al.  Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies , 1995 .

[24]  S. Boyce,et al.  Mitogenic and melanogenic stimulation of normal human melanocytes by melanotropic peptides. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Cancedda,et al.  Alpha melanocyte stimulating hormone (alpha MSH) stimulates normal human melanocyte growth by binding to high-affinity receptors. , 1993, Journal of cell science.

[26]  J. Wikberg,et al.  Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA , 1992, FEBS letters.

[27]  M. Mortrud,et al.  The cloning of a family of genes that encode the melanocortin receptors. , 1992, Science.

[28]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[29]  T. Fitzpatrick The validity and practicality of sun-reactive skin types I through VI. , 1988, Archives of Dermatology.

[30]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[31]  S. Ito,et al.  Melanocyte-stimulating hormone, tyrosinase activity and the regulation of eumelanogenesis and phaeomelanogenesis in the hair follicular melanocytes of the mouse. , 1986, The Journal of endocrinology.

[32]  R. Westendorp,et al.  Relation between smoking and skin cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  D. Duffy,et al.  Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? , 2000, American journal of human genetics.

[34]  R. Cancedda,et al.  Melanocyte stimulating hormone ( MSH ) stimulates normal human melanocyte growth by binding to high-affinity receptors , 1999 .

[35]  D. Gawkrodger,et al.  alpha-Melanocyte stimulating hormone inhibits tumour necrosis factor-alpha stimulated intercellular adhesion molecule-1 expression in normal cutaneous human melanocytes and in melanoma cell lines. , 1998, The British journal of dermatology.

[36]  E. Healy,et al.  Melanocortin receptors, red hair, and skin cancer. , 1997, The journal of investigative dermatology. Symposium proceedings.

[37]  R. Cone,et al.  Identification of common polymorphisms in the coding sequence of the human MSH receptor (MCIR) with possible biological effects , 1997, Human mutation.

[38]  D. I. Våge,et al.  The melanocortin receptors: agonists, antagonists, and the hormonal control of pigmentation. , 1996, Recent progress in hormone research.

[39]  B. Gilchrest,et al.  Proopiomelanocortin, its derived peptides, and the skin. , 1996, The Journal of investigative dermatology.

[40]  J. Lunec,et al.  Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells. , 1990, Pathobiology : journal of immunopathology, molecular and cellular biology.

[41]  T. Fitzpatrick The validity and practicality of sun-reactive skin types I through VI. , 1988, Archives of dermatology.